SCHOTT Pharma AG & Co. KGaA Cash Flow Reinvestment Rate
SCHOTT Pharma AG & Co. KGaA cash flow reinvestment rate. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Cash Flow Reinvestment Rate of 1.70x as of September 2024, reinvesting €129.22 Million (capex €64.68 Million plus investments €-64.53 Million) from operating cash flow of €75.97 Million. See SCHOTT Pharma AG & Co. KGaA (1SXP) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Cash flow reinvestment rate of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. Historical reinvestment intensity for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Explore 1SXP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
SCHOTT Pharma AG & Co. KGaA Cash Flow Reinvestment Rate by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA cash flow reinvestment rate by year from 2020 to 2024. Year-by-year capital reinvestment analysis for SCHOTT Pharma AG & Co. KGaA. For the full cash flow conversion analysis, see cash efficiency ratio of SCHOTT Pharma AG & Co. KGaA.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.29x | €291.23 Million | €225.33 Million | €145.30 Million | ▼ -32.3% |
| 2023 | 1.91x | €346.94 Million | €181.65 Million | €175.52 Million | ▲ +18.0% |
| 2022 | 1.62x | €294.82 Million | €182.12 Million | €152.69 Million | ▲ +10.0% |
| 2021 | 1.47x | €194.52 Million | €132.21 Million | €98.63 Million | ▼ -7.8% |
| 2020 | 1.60x | €166.53 Million | €104.40 Million | €85.31 Million | — |